During the past decade, Ospedale Sandro Pertini conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 8 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Sandro Pertini" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Sandro Pertini" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Associazione Nazionale Medici Cardiologi Ospedalieri" with 1 trials as a collaborator, "BMR Genomics" with 1 trials as a collaborator, "Cardialysis B.V." with 1 trials as a collaborator and "Doppel Farmaceutici" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Sandro Pertini" are "Ulcerative Colitis" (8 trials), "Coronary Artery Disease" (6 trials), "Coronary Artery Stenosis" (3 trials), "Coronary Artery Restenosis" (2 trials) and "Coronary Disease" (2 trials). Many other conditions were trialed in "Ospedale Sandro Pertini" in a lesser frequency.

Most popular intervention types in "Ospedale Sandro Pertini" are "Drug" (19 trials), "Device" (8 trials), "Procedure" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Etrasimod" (3 trials), "Etrolizumab" (2 trials), "Mirikizumab" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Sandro Pertini" are 28 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Sandro Pertini". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Ospedale Sandro Pertini, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Sandro Pertini, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".